Literature DB >> 31178216

Time to recurrence and patient survival in recurrent oral squamous cell carcinoma.

Annelies Weckx1, Maximilian Riekert2, Andrea Grandoch2, Volker Schick3, Joachim E Zöller2, Matthias Kreppel2.   

Abstract

OBJECTIVES: Tumour relapse remains one of the major problems in managing oral squamous cell carcinoma (OSCC) with mortality rates of up to 92%. Early recurrences have a worse prognosis than late relapses. However, few has been written about the influence of clinicopathological parameters on the timing of recurrence and the patient survival.
MATERIALS AND METHODS: Retrospective chart review of 159 patients with an OSCC recurrent disease. Exclusion criteria were neoadjuvant chemoradiotherapy, follow-up <6 weeks, perioperative death, second primaries and inadequate information on clinicopathological parameters. Statistical analysis was performed using univariate and multivariate analysis.
RESULTS: A significant correlation was found in the χ2-analysis between the timing of recurrence and the margin status (p = 0.020), lymph node ratio (p = 0.030) and grading (p = 0.003) of the primary tumour. In the multivariate survival analysis, the timing of recurrence (p < 0.001), margin status of the primary tumour (p = 0.023), presence of extracapsular spread in the primary tumour (p = 0.003) and performance of a salvage treatment (p < 0.001) were shown to be independent risk factors for overall survival.
CONCLUSION: For patients with a recurrent OSCC, the time to recurrence, margin status, extracapsular spread and the performance of a salvage treatment are independent prognostic factors for overall survival. Furthermore, a significant association exists between the moment of recurrence and the lymph node ratio, the margin status and grading of the primary tumour. This knowledge can allow for the development of individualised surveillance programs and like this, an earlier diagnosis and better second treatment chance in the case of a recurrence.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Oral Cancer; Prognosis; Recurrence; Risk factor; Squamous cell carcinoma; Survival

Mesh:

Year:  2019        PMID: 31178216     DOI: 10.1016/j.oraloncology.2019.05.002

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score.

Authors:  Yuji Shimizu; Ryo Ashida; Teiichi Sugiura; Yukiyasu Okamura; Katsuhisa Ohgi; Mihoko Yamada; Shimpei Otsuka; Takeshi Aramaki; Akifumi Notsu; Katsuhiko Uesaka
Journal:  Ann Surg Oncol       Date:  2022-06-06       Impact factor: 4.339

Review 2.  Are Survival Outcomes Different for Young and Old Patients with Oral and Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis.

Authors:  Swagatika Panda; Neeta Mohanty; Saurav Panda; Lora Mishra; Divya Gopinath; Alkananda Sahoo; Sumanth Kumbargere Nagraj; Barbara Lapinska
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

Review 3.  Tumor associated tissue eosinophilia in oral squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Nilookumari Choudhary; Gargi S Sarode; Monal Yuwanati; Nikunj Maniyar; Sachin C Sarode; Amol R Gadbail; Shailesh Gondivkar; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2020-11-23

Review 4.  Salvage Surgery in Recurrent Oral Squamous Cell Carcinoma.

Authors:  K S Rathan Shetty; Vinayak Kurle; P Greeshma; Veena B Ganga; Samskruthi P Murthy; Siddappa K Thammaiah; P Krishna Prasad; Purushottham Chavan; Rajshekar Halkud; R Krishnappa
Journal:  Front Oral Health       Date:  2022-01-28

5.  Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.

Authors:  Shen Zheng; Ran Wu; Yunlong Deng; Qiang Zhang
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  Impact of time to first relapse on long-term outcome in adult retroperitoneal sarcoma patients after radical resection.

Authors:  Huajie Guan; Mengmeng Liu; Shaohui Cai; Biyi Ou; Yuanxiang Guan; Yao Liang
Journal:  Int J Clin Oncol       Date:  2022-06-28       Impact factor: 3.850

7.  Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors:  Yue He; Zhonglong Liu; Surui Sheng; Weijin Gao; Xiao Tang; Xiaoguang Li; Chunyue Ma
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

8.  Prognosis Value of Immunoregulatory Molecules in Oral Cancer Microenvironment: An Immunohistochemical Study.

Authors:  Juan Francisco Peña-Cardelles; José Juan Pozo-Kreilinger; Giovanna Roncador; Jesús Esteban-Hernández; José Ernesto Moro-Rodríguez; Ana Sastre-Perona; Beatriz Castelo-Fernández; José Luis Cebrián-Carretero
Journal:  Biomedicines       Date:  2022-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.